This page needs to be proofread.
3 Tumor lysis syndrome
- Tumor lysis syndrome (spontaneous)
- Tumor lysis syndrome following antineoplastic drug chemotherapy
- Code first (T45.1-) to identify drug, if drug induced
- E88.4 Mitochondrial metabolism disorders
- Excludes1: disorders of pyruvate metabolism (E74.4)
- Kearns-Sayre syndrome (H49.81)
- Leber's disease (H47.22)
- Leigh's encephalopathy (G31.82)
- Mitochondrial myopathy, NEC (G71.3)
- Reye's syndrome (G93.7)
- E88.40 Mitochondrial metabolism disorder, unspecified
- E88.41 MELAS syndrome
- Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes
- E88.42 MERRF syndrome
- Myoclonic epilepsy associated with ragged-red fibers
- Code also: myoclonic epilepsy (G40.3-)
- E88.49 Other mitochondrial metabolism disorders
- Excludes1: disorders of pyruvate metabolism (E74.4)
- E88.8 Other specified metabolic disorders
- E88.81 Metabolic syndrome
- Dysmetabolic syndrome X
- E88.89 Other specified metabolic disorders
- Launois-Bensaude adenolipomatosis
- E88.81 Metabolic syndrome
- E88.9 Metabolic disorder, unspecified
E89 Postprocedural endocrine and metabolic complications and disorders, not elsewhere classified
- Excludes2: intraoperative complications of endocrine system organ or structure (E36.0-, E36.1-, E36.8)
- E89.0 Postprocedural hypothyroidism
- Postirradiation hypothyroidism
- Postsurgical hypothyroidism
- E89.1 Postprocedural hypoinsulinemia
- Postpancreatectomy hyperglycemia
- Postsurgical hypoinsulinemia
- Use additional code, if applicable, to identify:
- acquired absence of pancreas (Z90.89)
- diabetes mellitus (E11.-)
- insulin use (Z79.4)
- Excludes1: transient postprocedural hyperglycemia (R73.9)
- transient postprocedural hypoglycemia (E16.2)
- E89.2 Postprocedural hypoparathyroidism
- Parathyroprival tetany
- E89.3 Postprocedural hypopituitarism
- Postirradiation hypopituitarism
- E89.
